Prevalence of antibodies to hepatitis C virus in Spanish patients with hepatocellular carcinoma and hepatic cirrhosis.
about
Viral hepatitis and hepatocellular carcinomaHepatitis C virus core protein interacts with cellular putative RNA helicase.Nonstructural protein 5A of hepatitis C virus inhibits the function of karyopherin beta3Direct interaction of hepatitis C virus core protein with the cellular lymphotoxin-beta receptor modulates the signal pathway of the lymphotoxin-beta receptorNew advances in hepatocellular carcinomaHistorical review of the causes of cancerNon-A, non-B hepatitis.Hepatitis C virus. A review.Evidence for hepatitis C viral infection in patients with primary hepatocellular carcinomaPoliovirus/Hepatitis C virus (internal ribosomal entry site-core) chimeric viruses: improved growth properties through modification of a proteolytic cleavage site and requirement for core RNA sequences but not for core-related polypeptides.Efficacy of longterm interferon treatment in chronic liver disease evaluated by sensitive polymerase chain reaction assay for hepatitis C virus RNASexual transmission of hepatitis C virus and its relation with hepatitis B virus and HIVClinical guidelines on the management of hepatitis CDetection of replicative hepatitis C virus sequences in hepatocellular carcinomaNS3-4A of hepatitis C virus is a chymotrypsin-like proteaseHepatitis C virus core protein cooperates with ras and transforms primary rat embryo fibroblasts to tumorigenic phenotypeThe clinical virology of hepatitis C virusCharacterization of the hepatitis C virus-encoded serine proteinase: determination of proteinase-dependent polyprotein cleavage sitesSuppression of hepatitis B virus expression and replication by hepatitis C virus core protein in HuH-7 cellsHepatologyDiscrimination of hepatitis C virus in liver tissues from different patients with hepatocellular carcinomas by direct nucleotide sequencing of amplified cDNA of the viral genomeHepatocellular carcinoma: Epidemiology, risk factors and pathogenesisHepatitis C virus genotype 3a infection and hepatocellular carcinoma: Pakistan experienceMolecular cloning of the human hepatitis C virus genome from Japanese patients with non-A, non-B hepatitisAlcohol use disorder and its impact on chronic hepatitis C virus and human immunodeficiency virus infectionsHepatitis C virus and hepatocarcinogenesisThe changing epidemiology and aetiology of hepatocellular carcinoma from 1969 through 2013 in Alaska Native people.Chronic hepatitis C: the virus, its discovery and the natural history of the disease.Minimally invasive image-guided therapy for inoperable hepatocellular carcinoma: What is the evidence today?MRI versus 64-row MDCT for diagnosis of hepatocellular carcinoma.Association between chronic hepatitis C infection and hepatocellular carcinoma in a Scottish populationSerum levels of soluble Fas, soluble tumor necrosis factor-receptor II, interleukin-2 receptor and interleukin-8 as early predictors of hepatocellular carcinoma in Egyptian patients with hepatitis C virus genotype-4Hepatitis C virus core protein enhances NF-kappaB signal pathway triggering by lymphotoxin-beta receptor ligand and tumor necrosis factor alpha.Hepatitis C and alcohol.Phase i study evaluating the treatment of patients with hepatocellular carcinoma (HCC) with carbon ion radiotherapy: the PROMETHEUS-01 trialIncidence of primary cholangiocellular carcinoma of the liver in japanese patients with hepatitis C virus-related cirrhosis.Hepatitis C virus and alcohol.Hepatocellular carcinoma: clinicopathological profile and challenges of management in a resource-limited setting.Outcome of small liver nodules detected by computed tomographic angiography in patients with hepatocellular carcinoma.Hepatitis C virus infection and risk of cancer: a population-based cohort study.
P2860
Q21245597-A00E1EFB-B5CF-41B7-8665-FD6DFE42CF66Q22009013-5ACB92EC-3FFF-4FB1-9BD8-0BFB3AF67840Q22254038-2ACCC772-F8DD-4878-A3D8-AF3738EC49B6Q24653498-EF682C14-3F98-403E-824D-F4926F08A569Q26749329-E56AA316-AA4A-49F8-BF1E-4C57C4EB4E9EQ26767036-F89BD90F-661E-4CAC-B502-948211039CBAQ27469293-0D1A089C-EBB8-44A7-9A05-AE8C273B3DA1Q27469295-A18EDB12-502D-44D4-9B31-257C4CC61517Q27469317-AD98659E-5F54-46E2-9505-C15949588C9FQ27469345-4D131A75-96A3-4E84-99BF-9B5306BA939FQ27473016-1FBD2822-CE57-46EF-8B99-4C5721166EAFQ27477689-4537DE6A-D7E5-4480-B36B-734D3B918CDAQ27477946-0DF03519-AC04-4F92-B979-B8B01F7BBC7EQ27478449-EC03048B-89EF-4901-B37E-05A06C9D3E59Q27478468-D20A96EA-6D32-4613-BE25-2172D0B032B7Q27480393-CFF96818-3709-43E0-91B4-B17D928F0F0FQ27481239-97D685D6-47C1-43AC-82A5-AF689AA0E111Q27486027-78D376DB-B648-4AAA-86CD-2F05F541A8A1Q27486067-0D101304-DD91-4387-A0F1-58E45FF7E97DQ27486176-0EF45F0B-7D20-4092-978F-A635D3785773Q27488868-4C02945D-D176-4A47-8B6E-04E5CFAA8744Q27489394-E4115EF0-8306-4741-AB58-4A7E540BC1A2Q27490250-F4C75A6D-DF66-482E-AEC9-F0CAEFCD7D61Q27860811-3C7FC7EC-1BD7-42DD-A289-AD275D9C4FCAQ28070280-669AF86F-4034-476A-AE71-8F84A28E1177Q28283484-225D9EC9-66DA-4B48-8C39-249FD316A466Q30152009-9B287393-1DF7-45A8-9794-F9DF48311DDBQ30431528-A921B4BF-4E9C-4619-8212-F5E910012BA0Q30468280-B4AC0C7C-9AAC-47B2-85E6-CB18707A1D9AQ33555339-85F63F81-4CC5-4CCA-B7DF-C48CA83480F8Q33617717-1EB39330-05F6-42ED-B7B8-E367B8957436Q33640766-21F3CC9D-152B-4D1D-89C4-BF046F8D8A53Q33642411-6FFDEE80-1F35-4403-8CC9-7A6F436A8402Q33747334-2F50FC08-7FE4-43A6-8086-29CE0BC96694Q33818746-48C21B1F-E80B-47B3-AD40-2BFE85D18486Q33906429-4A92F6A9-D194-4C86-A3D9-B597A4B224ABQ33944512-D8CA37FB-3608-4928-8054-51291B1A5E17Q34000108-1D5D07C5-F0FE-4FF1-B51C-4B2AB020B31FQ34130377-4EF44946-4B3C-4073-B1EB-33F8674881A0Q34144211-BAE1EE67-BBCB-4242-A7A6-F97627CA11D7
P2860
Prevalence of antibodies to hepatitis C virus in Spanish patients with hepatocellular carcinoma and hepatic cirrhosis.
description
1989 nî lūn-bûn
@nan
1989年の論文
@ja
1989年学术文章
@wuu
1989年学术文章
@zh
1989年学术文章
@zh-cn
1989年学术文章
@zh-hans
1989年学术文章
@zh-my
1989年学术文章
@zh-sg
1989年學術文章
@yue
1989年學術文章
@zh-hant
name
Prevalence of antibodies to he ...... rcinoma and hepatic cirrhosis.
@en
Prevalence of antibodies to he ...... rcinoma and hepatic cirrhosis.
@nl
type
label
Prevalence of antibodies to he ...... rcinoma and hepatic cirrhosis.
@en
Prevalence of antibodies to he ...... rcinoma and hepatic cirrhosis.
@nl
prefLabel
Prevalence of antibodies to he ...... rcinoma and hepatic cirrhosis.
@en
Prevalence of antibodies to he ...... rcinoma and hepatic cirrhosis.
@nl
P2093
P50
P921
P1433
P1476
Prevalence of antibodies to he ...... rcinoma and hepatic cirrhosis.
@en
P2093
J M Barrera
J M Sanchez-Tapias
M Bruguera
P304
P356
10.1016/S0140-6736(89)91015-5
P407
P577
1989-10-01T00:00:00Z